Poseida Therapeutics Inc
NASDAQ:PSTX
Cash Flow Statement
Cash Flow Statement
Poseida Therapeutics Inc
Dec-2018 | Mar-2019 | Jun-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||||||
Net Income |
(44)
|
(58)
|
(86)
|
(87)
|
(102)
|
(104)
|
(138)
|
(130)
|
(139)
|
(155)
|
(163)
|
(125)
|
(145)
|
(142)
|
(29)
|
(64)
|
(45)
|
(29)
|
(131)
|
(123)
|
(109)
|
|
Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
6
|
6
|
6
|
|
Change in Deffered Taxes |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Stock-Based Compensation |
1
|
0
|
0
|
3
|
5
|
6
|
8
|
7
|
9
|
12
|
15
|
17
|
18
|
19
|
19
|
19
|
22
|
22
|
23
|
23
|
21
|
|
Other Non-Cash Items |
5
|
4
|
13
|
11
|
14
|
7
|
10
|
8
|
10
|
13
|
15
|
(2)
|
7
|
5
|
(1)
|
18
|
11
|
11
|
12
|
12
|
10
|
|
Cash Interest Paid |
1
|
2
|
3
|
3
|
3
|
3
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
6
|
7
|
7
|
8
|
8
|
|
Change in Working Capital |
1
|
0
|
6
|
9
|
14
|
6
|
8
|
6
|
(4)
|
8
|
2
|
20
|
18
|
8
|
4
|
14
|
15
|
6
|
53
|
14
|
24
|
|
Cash from Operating Activities |
(38)
N/A
|
(53)
-39%
|
(67)
-27%
|
(65)
+3%
|
(73)
-13%
|
(89)
-23%
|
(119)
-33%
|
(113)
+5%
|
(130)
-14%
|
(130)
0%
|
(141)
-9%
|
(103)
+27%
|
(115)
-12%
|
(123)
-8%
|
(21)
+83%
|
(27)
-29%
|
(13)
+50%
|
(7)
+48%
|
(61)
-768%
|
(92)
-51%
|
(69)
+25%
|
|
Investing Cash Flow | ||||||||||||||||||||||
Capital Expenditures |
(1)
|
(2)
|
(3)
|
(5)
|
(8)
|
(15)
|
(18)
|
(17)
|
(14)
|
(7)
|
(5)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
|
Other Items |
0
|
0
|
(19)
|
(37)
|
(40)
|
(1)
|
(256)
|
(188)
|
(60)
|
(18)
|
275
|
225
|
100
|
(42)
|
(114)
|
(199)
|
(203)
|
(79)
|
(91)
|
42
|
70
|
|
Cash from Investing Activities |
(1)
N/A
|
(2)
-21%
|
(22)
-1 312%
|
(42)
-94%
|
(48)
-13%
|
(16)
+66%
|
(274)
-1 593%
|
(204)
+25%
|
(74)
+64%
|
(25)
+67%
|
271
N/A
|
222
-18%
|
97
-56%
|
(45)
N/A
|
(118)
-164%
|
(203)
-73%
|
(207)
-2%
|
(83)
+60%
|
(94)
-14%
|
39
N/A
|
68
+73%
|
|
Financing Cash Flow | ||||||||||||||||||||||
Net Issuance of Common Stock |
31
|
117
|
172
|
150
|
64
|
112
|
318
|
310
|
310
|
206
|
2
|
3
|
3
|
3
|
77
|
77
|
78
|
78
|
17
|
17
|
15
|
|
Net Issuance of Debt |
10
|
20
|
20
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
30
|
30
|
30
|
0
|
0
|
0
|
0
|
0
|
|
Other |
14
|
13
|
18
|
5
|
9
|
3
|
4
|
4
|
(0)
|
1
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
Cash from Financing Activities |
54
N/A
|
150
+177%
|
211
+40%
|
164
-22%
|
73
-56%
|
115
+58%
|
322
+179%
|
314
-2%
|
310
-1%
|
207
-33%
|
2
-99%
|
3
+9%
|
31
+1 146%
|
31
0%
|
105
+236%
|
105
0%
|
77
-27%
|
77
0%
|
16
-79%
|
16
0%
|
15
-8%
|
|
Change in Cash | ||||||||||||||||||||||
Net Change in Cash |
15
N/A
|
96
+548%
|
122
+27%
|
57
-53%
|
(48)
N/A
|
10
N/A
|
(71)
N/A
|
(4)
+95%
|
107
N/A
|
53
-51%
|
132
+150%
|
122
-7%
|
14
-89%
|
(137)
N/A
|
(33)
+76%
|
(125)
-279%
|
(143)
-15%
|
(13)
+91%
|
(139)
-968%
|
(37)
+74%
|
13
N/A
|
|
Free Cash Flow | ||||||||||||||||||||||
Free Cash Flow |
(39)
N/A
|
(54)
-38%
|
(70)
-29%
|
(70)
+0%
|
(81)
-16%
|
(105)
-29%
|
(137)
-31%
|
(130)
+5%
|
(143)
-10%
|
(137)
+5%
|
(146)
-7%
|
(105)
+28%
|
(118)
-12%
|
(126)
-7%
|
(25)
+80%
|
(31)
-25%
|
(17)
+43%
|
(11)
+37%
|
(64)
-484%
|
(95)
-49%
|
(72)
+25%
|